Stina Gröhn

Medicine & Life Sciences

1. Rotavirus 100%
2. Norovirus 92%
3. Rotavirus VP6 protein 84%
4. coronavirus receptor 79%
5. Virion 78%
6. influenza A virus M2 protein 77%
7. Capsid Proteins 75%
8. Heterophile Antigens 61%
9. Vaccines 59%
10. Severe Acute Respiratory Syndrome 55%
11. Peptides 54%
12. Nanostructures 50%
13. Influenza A virus 47%
14. Antigen Presentation 46%
15. Proteins 43%
16. Recombinant Proteins 42%
17. Antigen-Presenting Cells 41%
18. Dendritic Cells 38%
19. Antigens 36%
20. Carrier Proteins 36%
21. Immunization 36%
22. Technology 35%
23. Bone Marrow 31%
24. Amino Acids 30%
25. Coronavirus 27%
26. T-Lymphocytes 26%
27. Nanospheres 21%
28. Nanotubes 19%
29. Genes 19%
30. Coronavirus Spike Glycoproteins 18%
31. angiotensin converting enzyme 2 15%
32. Adaptive Immunity 14%
33. B-Lymphocyte Epitopes 14%
34. Virus-Like Particle Vaccines 13%
35. Protein S 13%
36. T-Lymphocyte Epitopes 12%
37. Baculoviridae 12%
38. Nanoparticles 12%
39. Pandemics 11%
40. Insecta 11%
41. In Vitro Techniques 10%
42. Protein Domains 10%
43. Immunity 8%
44. Antibodies 8%
45. B-Lymphocytes 8%
46. Messenger RNA 6%
47. Aluminum Hydroxide 5%